| scholarly article | Q13442814 |
| P50 | author | Jason Kindrachuk | Q47036869 |
| Robert E. W. Hancock | Q53441913 | ||
| Håvard Jenssen | Q56697456 | ||
| P2093 | author name string | Anastasia Nijnik | |
| Donna M Easton | |||
| Shuhua Ma | |||
| Laurence Madera | |||
| Sarah C Mullaly | |||
| Matthew L Mayer | |||
| Matthew Waldbrook | |||
| Melissa R Elliott | |||
| P2860 | cites work | Establishment and characterization of a human acute monocytic leukemia cell line (THP-1) | Q28276146 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2539-2550 | |
| P577 | publication date | 2010-01-27 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment | |
| P478 | volume | 184 |
| Q92222851 | A Novel Adjuvant "Sublancin" Enhances Immune Response in Specific Pathogen-Free Broiler Chickens Inoculated with Newcastle Disease Vaccine |
| Q91440678 | A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice |
| Q37263526 | A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killing |
| Q33927961 | A peptide of heparin cofactor II inhibits endotoxin-mediated shock and invasive Pseudomonas aeruginosa infection. |
| Q28488709 | Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models |
| Q37386135 | An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities |
| Q39066110 | Anti-inflammatory Properties of Antimicrobial Peptides and Peptidomimetics: LPS and LTA Neutralization. |
| Q83151639 | Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations |
| Q52592947 | Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds. |
| Q47723258 | Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo |
| Q41747279 | Antimicrobial effects of helix D-derived peptides of human antithrombin III |
| Q89927176 | Antimicrobial host defence peptides: functions and clinical potential |
| Q42275047 | Antimicrobial host defensins - specific antibiotic activities and innate defense modulation |
| Q26850135 | Antimicrobial peptides and complement in neonatal hypoxia-ischemia induced brain damage |
| Q37689800 | Avian antimicrobial host defense peptides: from biology to therapeutic applications. |
| Q50034251 | BT cationic peptides: small peptides that modulate innate immune responses of chicken heterophils and monocytes |
| Q37874201 | Bacterial resistance mechanisms against host defense peptides |
| Q54652255 | Cathelicidin Peptide LL-37 Modulates TREM-1 Expression and Inflammatory Responses to Microbial Compounds |
| Q99711549 | Cathelicidin and Calprotectin Are Disparately Altered in Murine Models of Inflammatory Arthritis and Airway Inflammation |
| Q38022156 | Cationic host defence peptides: multifaceted role in immune modulation and inflammation. |
| Q92173521 | Cecropin-like antimicrobial peptide protects mice from lethal E.coli infection |
| Q57462992 | Characterization of host responses during acute lung infection in the lungs and blood and after treatment with the synthetic immunomodulatory peptide IDR-1002 |
| Q92128444 | Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors |
| Q48010870 | Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria |
| Q50145801 | Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus |
| Q39328333 | Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles. |
| Q34058050 | Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsis |
| Q37717143 | Evaluation of the Immunomodulatory Activity of the Chicken NK-Lysin-Derived Peptide cNK-2. |
| Q36090102 | High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides |
| Q27331817 | Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsis |
| Q34495298 | Host defense peptides: an alternative as antiinfective and immunomodulatory therapeutics |
| Q87514916 | Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation |
| Q37036638 | Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection |
| Q38162670 | Immune modulation by multifaceted cationic host defense (antimicrobial) peptides |
| Q55325660 | Immunomodulation and effects on microbiota after in ovo administration of chicken cathelicidin-2. |
| Q37800180 | Immunomodulators as adjuvants for vaccines and antimicrobial therapy |
| Q35915514 | Immunomodulatory and Anti-Inflammatory Activities of Chicken Cathelicidin-2 Derived Peptides |
| Q38148589 | Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers. |
| Q37103094 | In vitro testing of African traditional medicines for cytotoxic, immune modulatory and anti-HIV activities |
| Q92659107 | Inhibition of CREB-mediated ZO-1 and activation of NF-κB-induced IL-6 by colonic epithelial MCT4 destroys intestinal barrier function |
| Q64269056 | Inhibitory Effects of Antimicrobial Peptide JH-3 on Serovar Typhimurium Strain CVCC541 Infection-Induced Inflammatory Cytokine Release and Apoptosis in RAW264.7 Cells |
| Q48219322 | Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-ĸB-sensitive pathways |
| Q34373912 | Innate defense regulator peptide 1018 in wound healing and wound infection |
| Q50702854 | Innate defense regulator peptide 1018 protects against perinatal brain injury. |
| Q40483231 | Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice |
| Q39251694 | Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory |
| Q39332189 | Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma. |
| Q35802766 | Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production |
| Q46290278 | Mechanisms of the Innate Defense Regulator Peptide-1002 Anti-Inflammatory Activity in a Sterile Inflammation Mouse Model |
| Q37994068 | Modulating immunity as a therapy for bacterial infections |
| Q35617710 | Modulation of interleukin-1β-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts |
| Q37875767 | Multifunctional cationic host defence peptides and their clinical applications |
| Q37248305 | Nematode Peptides with Host-Directed Anti-inflammatory Activity Rescue Caenorhabditis elegans from a Burkholderia pseudomallei Infection |
| Q33743958 | Neutrophil depletion suppresses pulmonary vascular hyperpermeability and occurrence of pulmonary edema caused by hantavirus infection in C.B-17 SCID mice |
| Q42262598 | Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies |
| Q42014234 | Peptide IDR-1002 Inhibits NF-κB Nuclear Translocation by Inhibition of IκBα Degradation and Activates p38/ERK1/2-MSK1-Dependent CREB Phosphorylation in Macrophages Stimulated with Lipopolysaccharide |
| Q38263995 | Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections |
| Q37598400 | Peptide design for antimicrobial and immunomodulatory applications |
| Q57929840 | Perinatal Hypoxic-Ischemic Encephalopathy and Neuroprotective Peptide Therapies: A Case for Cationic Arginine-Rich Peptides (CARPs) |
| Q33700825 | Perspectives for clinical use of engineered human host defense antimicrobial peptides |
| Q39173330 | Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs |
| Q92405105 | Porcine Beta-Defensin 2 Provides Protection Against Bacterial Infection by a Direct Bactericidal Activity and Alleviates Inflammation via Interference With the TLR4/NF-κB Pathway |
| Q55188486 | Prevention of Cyclophosphamide-Induced Immunosuppression in Mice with the Antimicrobial Peptide Sublancin. |
| Q36941335 | Protective effect of in ovo treatment with the chicken cathelicidin analog D-CATH-2 against avian pathogenic E. coli |
| Q28079028 | Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases |
| Q90147842 | Selection of adjuvants for vaccines targeting specific pathogens |
| Q26774480 | Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis |
| Q27676333 | Structure, Dynamics, and Antimicrobial and Immune Modulatory Activities of Human LL-23 and Its Single-Residue Variants Mutated on the Basis of Homologous Primate Cathelicidins |
| Q35004988 | Structure-activity studies and therapeutic potential of host defense peptides of human thrombin |
| Q58781151 | Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens and |
| Q55432018 | Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens. |
| Q92243227 | Synthetic Cationic Peptide IDR-1002 and Human Cathelicidin LL37 Modulate the Cell Innate Response but Differentially Impact PRRSV Replication in vitro |
| Q34544517 | Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation |
| Q47118800 | Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection |
| Q46008344 | Synthetic immunomodulatory peptide IDR-1002 enhances monocyte migration and adhesion on fibronectin. |
| Q36122395 | Synthetic mimics of antimicrobial peptides with immunomodulatory responses |
| Q58750549 | TFPI-2 Protects Against Gram-Negative Bacterial Infection |
| Q49490467 | The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs |
| Q35067228 | The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsis. |
| Q83285857 | The antimicrobial peptide hLF1-11 drives monocyte-dendritic cell differentiation toward dendritic cells that promote antifungal responses and enhance Th17 polarization |
| Q57456516 | The immunomodulatory effect of antimicrobial peptide HPA3P restricts Brucella abortus 544 infection in BALB/c mice |
| Q43435879 | The innate defense regulator peptides IDR-HH2, IDR-1002, and IDR-1018 modulate human neutrophil functions |
| Q90641553 | The potential for immunoglobulins and host defense peptides (HDPs) to reduce the use of antibiotics in animal production |
| Q51737656 | The respiratory syncytial virus fusion protein formulated with a polymer-based adjuvant induces multiple signaling pathways in macrophages. |
| Q36132248 | The role of the Src family kinase Lyn in the immunomodulatory activities of cathelicidin peptide LL-37 on monocytic cells |
| Q42205540 | The specificity of protection against cationic antimicrobial peptides by lactoferrin binding protein B. |
| Q28492572 | The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS |
| Q38401924 | Therapeutic utility of antibacterial peptides in wound healing |
| Q28485935 | Ultrashort cationic lipopeptides and lipopeptoids selectively induce cytokine production in macrophages |
| Q36982055 | Wnt5a stimulates chemotactic migration and chemokine production in human neutrophils |
Search more.